ARMO BioSciences Files For IPO
Redwood City-based ARMO BioSciences file for an IPO last week, saying that it is looking to raise up to $86.25M in an IPO on the NASDAQ Global Select Market. The company has applied to list as ARMO. The IPO is being underwritten by Jefferies, Leerink Partners, BMO Capital Markets, and Baird. ARMO is venture backed by Kleiner Perkins Caufield & Byers, OrbiMed Advisors, DAG Ventures, GV (formerly Google Ventures), and Decheng Capital China Life Sciences Fund. ARMO BioSciences is focused on late stage immuno-oncology therapeutics.
posted on Wednesday, January 3, 2018
Related companies:
Armo Biosciences
Related stories:
> ARMO BioSciences Takes $50M
> ARMO BioSciences Adds $67M For Cancer Treatments
> 3-V Biosciences Finds $20M In Funding
> Pacific Biosciences Raises $50M
> Imago Biosciences Sees $26.5M
silicontap.com Home